&nbsp;

DiagnosticImagingClinicalIndicationforScanandPriorityLevelExamples

May 2020

Document

DiagnosticImagingDefinitions

May 2020

Regimen

DHAP+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Curative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma

ODB - General Benefit

dexamethasone

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jun 2020

Regimen

DCRBDOXO

Cancer Type:

Sarcoma,

Soft Tissue

Intent: Adjuvant, Curative, Palliative

Drugs Used:

dacarbazine,

DOXOrubicin

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2020

Regimen

DEXAPOMA+ISAT

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

New Drug Funding Program

Isatuximab - In Combination with Pomalidomide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Exceptional Access Program

pomalidomide - In combination with isatuximab and dexamethasone for relapsed or refractory multiple myeloma, according to specific criteria

Drugs Used:

Quick Link(s):

Regimen Monograph

Feb 2024

Regimen

DEXASELI

Cancer Type:

Hematologic,

Multiple Myeloma

Intent: Palliative

Funding:

ODB - General Benefit

dexamethasone

Drugs Used:

selinexor (Unfunded),

dexamethasone

... Show more tags

Quick Link(s):

Regimen Monograph

Aug 2020

Document

tomMcHughProfile.png

Dec 2020

Dépistage du cancer du col de l’utérus à 25 ans

Tumeurs neuroendocriniennes (TNE)

Document

TobaccoWiseFNIMBrochureMetis.pdf

Jan 2021

Document